Literature DB >> 22258373

[Castration-resistant prostate cancer: surgical and radio-oncological therapeutic options].

S Preusser1, P M Putora, L Plasswilm, H P Schmid.   

Abstract

Treatment of patients suffering from castration-resistant prostate cancer is a challenge for the attending physician. Due to the polysymptomatic nature of this disease, multidisciplinary cooperation (urology, radiation oncology, medical oncology, palliative care, orthopaedics, neurosurgery) is the centre of attention. Different surgical and radio-oncological therapeutic options are available based on different stages of this disease. Optimizing quality of life should always be the focus of attention in these patients.

Entities:  

Mesh：

Year:  2012        PMID： 22258373     DOI： 10.1007/s00120-011-2742-0

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


  15 in total

Review 1.  The problem of obstruction in prostate cancer.

Authors:  H P Schmid
Journal:  Urol Res       Date:  1991

Review 2.  [Treatment of metastatic bone disease and treatment-induced osteoporosis in prostate cancer. Evolution of osteoprotective strategies].

Authors:  T Todenhöfer; C Schwentner; D Schilling; G Gakis; A Stenzl
Journal:  Urologe A       Date:  2011-09       Impact factor: 0.639

3.  EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.

Authors:  Nicolas Mottet; Joaquim Bellmunt; Michel Bolla; Steven Joniau; Malcolm Mason; Vsevolod Matveev; Hans-Peter Schmid; Theo Van der Kwast; Thomas Wiegel; Filiberto Zattoni; Axel Heidenreich
Journal:  Eur Urol       Date:  2011-01-25       Impact factor: 20.096

4.  [Value of cystoprostatectomy in locally advanced prostate carcinoma].

Authors:  N Zantl; J E Gschwend
Journal:  Urologe A       Date:  2008-11       Impact factor: 0.639

Review 5.  Hormone-refractory and metastatic prostate cancer - palliative radiotherapy.

Authors:  Lutz Moser; Tina Schubert; Wolfgang Hinkelbein
Journal:  Front Radiat Ther Oncol       Date:  2008

6.  Palliative transurethral prostate resection for bladder outlet obstruction in patients with locally advanced prostate cancer.

Authors:  Donald S Crain; Christopher L Amling; Christopher J Kane
Journal:  J Urol       Date:  2004-02       Impact factor: 7.450

Review 7.  Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel.

Authors:  M Aapro; P A Abrahamsson; J J Body; R E Coleman; R Colomer; L Costa; L Crinò; L Dirix; M Gnant; J Gralow; P Hadji; G N Hortobagyi; W Jonat; A Lipton; A Monnier; A H G Paterson; R Rizzoli; F Saad; B Thürlimann
Journal:  Ann Oncol       Date:  2007-09-28       Impact factor: 32.976

Review 8.  Palliative radiotherapy trials for bone metastases: a systematic review.

Authors:  Edward Chow; Kristin Harris; Grace Fan; May Tsao; Wai M Sze
Journal:  J Clin Oncol       Date:  2007-04-10       Impact factor: 44.544

9.  Palliative prostate radiotherapy for symptomatic advanced prostate cancer.

Authors:  Omar S Din; Narottam Thanvi; Catherine J Ferguson; Peter Kirkbride
Journal:  Radiother Oncol       Date:  2009-05-21       Impact factor: 6.280

10.  Effects of skeletal morbidities on longitudinal patient-reported outcomes and survival in patients with metastatic prostate cancer.

Authors:  Venita DePuy; Kevin J Anstrom; Liana D Castel; Kevin A Schulman; Kevin P Weinfurt; Fred Saad
Journal:  Support Care Cancer       Date:  2007-07       Impact factor: 3.359
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.